Is Lakefront Biotherapeutics Nv Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: LKFT) stock is to Hold LKFT stock.
Out of 2 analysts, 0 (0%) are recommending LKFT as a Strong Buy, 0 (0%) are recommending LKFT as a Buy, 2 (100%) are recommending LKFT as a Hold, 0 (0%) are recommending LKFT as a Sell, and 0 (0%) are recommending LKFT as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year LKFT price target, the average LKFT price target is $26.00, with the highest LKFT stock price forecast at $26.00 and the lowest LKFT stock price forecast at $26.00.
On average, Wall Street analysts predict that Lakefront Biotherapeutics Nv's share price could fall to $26.00 by Aug 11, 2027. The average Lakefront Biotherapeutics Nv stock price prediction forecasts a potential downside of 9.5% from the current LKFT share price of $28.73.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.